http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2010002419-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cafbdf5d81db4f8a667c09d105133b1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1146c878be3e795ee1811ffdbf8276a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b7ceb0e8143c7e385a6b1a1a558c62f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7023f07b53830e2f4695286ea46ccdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43fce7e3938dc6db03202e9b21eb2eec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_371bca5f83e254403fb2adcad11e0402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d09af654157affa2bef0c69930a78fba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d387a0099d594cb71890ea194b6baed
publicationDate 2010-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2010002419-A
titleOfInvention (CICLOPROPILFENIL) PHENYLOXAMIDS, METHOD FOR PRODUCTION AND USE AS A MEDICINAL PRODUCT.
abstract The invention relates to (cyclopropylphenyl) phenyloxamides and their physiologically tolerated salts. The invention relates to compounds of the formula I (See formula I) wherein R1, R2, R3, R4, R5, R6, R7, R8 and m have the indicated meanings, and their physiologically tolerated salts. The compounds are suitable, for example, for the treatment of diabetes.
priorityDate 2007-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67263479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410533113

Total number of triples: 31.